Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 39Anemia, Refractory, with Excess of Blasts 39Leukemia, Myelomonocytic, Chronic 36Precursor Cell Lymphoblastic Leukemia-Lymphoma 35Myelodysplastic Syndromes 35Leukemia 30Congenital Abnormalities 26Leukemia, Myeloid, Chronic-Phase 25Leukemia, Lymphocytic, Chronic, B-Cell 24Myeloproliferative Disorders 23Lymphoma, Non-Hodgkin 22Multiple Myeloma 21Hodgkin Disease 21Leukemia, Myeloid, Accelerated Phase 20Lymphoma, Follicular 19Primary Myelofibrosis 18Anemia, Refractory 17Lymphoma, Mantle-Cell 16Lymphoma 16Burkitt Lymphoma 16Blast Crisis 16Lymphoma, Large-Cell, Immunoblastic 15Lymphoma, Large B-Cell, Diffuse 15Lymphoma, B-Cell, Marginal Zone 15Polycythemia Vera 14Waldenstrom Macroglobulinemia 12Neoplasms, Plasma Cell 12Anemia, Aplastic 11Thrombocythemia, Essential 10Myelodysplastic-Myeloproliferative Diseases 10

Interventions

angiotensin I (1-7) 1Transplantation 1Peripheral Blood Stem Cell Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphopenia × Peripheral Blood Stem Cell Transplantation × Classical hematology × Clear all
NCT01660347 2025-05-02

Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant

Thomas Jefferson University

Phase NA Withdrawn
Classical hematologyOther hematologic neoplasm

Anemia, Lymphopenia, Neutropenia, Thrombocytopenia, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡